The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation.

The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation.

Prostate cancer is the most commonly diagnosed cancer, with an estimated 240,000 new cases reported annually in the United States. Due to early detection and advances in therapies, more than 90% of patients will survive 10 years post diagnosis and treatment. Radiation is a treatment option often use...

Full description

Bibliographic Details
Main Authors: Rebecca E Oberley-Deegan, Joshua J Steffan, Kyle O Rove, Kathryn M Pate, Michael W Weaver, Ivan Spasojevic, Barbara Frederick, David Raben, Randall B Meacham, James D Crapo, Hari K Koul
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3440381?pdf=render

Internet

http://europepmc.org/articles/PMC3440381?pdf=render

Similar Items